Robert Bell
Hôpital Maisonneuve-Rosemont
20 Papers
81 Citations
Robert Bell is an academic researcher from Hôpital Maisonneuve-Rosemont. The author has contributed to research in topics: Hyperparathyroidism & Secondary hyperparathyroidism. The author has an hindex of 8, co-authored 20 publications. Previous affiliations of Robert Bell include Université de Montréal.
Chat about Author
Papers
Randomized Clinical Trial of Sodium Polystyrene Sulfonate for the Treatment of Mild Hyperkalemia in CKD
Laurence Lepage,Anne-Claude Dufour,Jessica Doiron,Katia Handfield,Katherine Desforges,Robert Bell,Michel Vallée,Michel Savoie,Sylvie Perreault,Louis-Philippe Laurin,Vincent Pichette,Jean-Philippe Lafrance +11 more
TL;DR: Sodium polystyrene sulfonate was superior to placebo in reducing serum potassium over 7 days in patients with mild hyperkalemia and CKD.
142
Development and validation of the PAIR (Pharmacotherapy Assessment in Chronic Renal Disease) criteria to assess medication safety and use issues in patients with CKD.
Jean-François Desrochers,Jean-François Desrochers,Jean-Philippe Lemieux,Claudia Morin-Bélanger,François Paradis,François Paradis,Anne Lord,Robert Bell,Djamal Berbiche,Patricia Quintana Barcena,Noémie Charbonneau Séguin,Noémie Charbonneau Séguin,Katherine Desforges,Marie-Ève Legris,Marie-Ève Legris,Patricia Sauvé,Lyne Lalonde +16 more
TL;DR: The prevalence of DRPs requiring the intervention of community pharmacists is high in patients with CKD and the PAIR criteria are reliable, but their responsiveness remains to be shown.
41
Pharmacist web-based training program on medication use in chronic kidney disease patients: Impact on knowledge, skills, and satisfaction.†
Marie-Ève Legris,Noémie Charbonneau Séguin,Katherine Desforges,Patricia Sauvé,Anne Lord,Robert Bell,Djamal Berbiche,Jean-François Desrochers,Jean-Philippe Lemieux,Claudia Morin-Bélanger,François Ste-Marie Paradis,Lyne Lalonde +11 more
TL;DR: A Web‐based training program was developed based on a list of significant drug‐related problems in CKD patients requiring a pharmaceutical intervention that improved community pharmacists' knowledge and skills over a short time span.
33
Community Pharmacist Training-and-Communication Network and Drug-Related Problems in Patients With CKD: A Multicenter, Cluster-Randomized, Controlled Trial.
Lyne Lalonde,Patricia Quintana-Bárcena,Anne Lord,Robert Bell,Valérie Clément,Anne-Marie Daigneault,Anne-Marie Daigneault,Marie-Ève Legris,Sara Letendre,Marie Mouchbahani,Ghaya Jouini,Joelle Azar,Élisabeth Martin,Djamal Berbiche,Stephanie Beaulieu,Sébastien Beaunoyer,Émilie Bertin,Marianne Bouvrette,Noémie Charbonneau-Séguin,Jean-François Desrochers,Katherine Desforges,Ariane Dumoulin-Charette,Sébastien Dupuis,Maryame El Bouchikhi,Roxanne Forget,Marianne Guay,Jean-Phillippe Lemieux,Claudia Morin-Bélanger,Isabelle Noël,Stephanie Ricard,Patricia Sauvé,François Paradis +31 more
TL;DR: Providing community pharmacists with essential clinical data, appropriate training, and support from hospital pharmacist with expertise in nephrology increases pharmacists' knowledge and reduces drug-related problems in patients with CKD who are followed up in clinics incorporating a multidisciplinary health care team.
26